STOCK TITAN

Consolidated Edison Inc 424B Filings

ED NYSE

Every 424B that Consolidated Edison Inc (ED) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow ED and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ED filings page.

Rhea-AI Summary

Consolidated Edison, Inc. registered an at-the-market equity program to offer up to $2,000,000,000 of its common shares under an equity distribution agreement with multiple dealer-agents and related forward purchasers and forward sellers.

The program permits sales on the NYSE or other markets, negotiated or block trades, and includes the option to enter into forward sale agreements that may be physically settled, cash settled, or net share settled; sales agents may receive commissions up to 1.0%. The prospectus supplement states the closing price was $106.39 per share on May 7, 2026.

Rhea-AI Summary

Consolidated Edison, Inc. intends to offer 7,000,000 common shares through a forward sale agreement with an affiliate of J.P. Morgan Securities LLC. The initial forward price is $110.81 per share and the company expects physical settlement by December 31, 2026, subject to adjustment and certain conditions.

The prospectus supplement states Con Edison would receive net proceeds of $775,670,000 upon full physical settlement (based on the initial forward price), that purchasers in the offering will not receive the $0.8875 per share dividend payable on March 16, 2026, and that shares outstanding were 361,302,689 as of February 20, 2026.

Rhea-AI Summary

Consolidated Edison, Inc. is offering 7,000,000 common shares through a forward sale arrangement with an affiliate of J.P. Morgan Securities LLC. The forward seller intends to borrow and sell the shares to the underwriter; the company will only receive proceeds upon full physical settlement of the forward sale agreement.

The company states the forward sale is expected to settle by December 31, 2026 if physically settled, the forward price will be adjusted daily by a floating interest-rate factor, and the issuer may elect cash settlement or net share settlement subject to certain conditions. Shares outstanding were 361,302,689 as of February 20, 2026, the NYSE closing price was $109.81 on February 20, 2026, and a dividend of $0.8875 per share was declared payable on March 16, 2026 (purchasers in the offering will not receive that dividend).